AKT1 and metabolic disease: In this study, SACe-N-C treatment observably increased the expression of PI3K, Akt and GSK3β, indicating that SACe-N-C intervention alleviates glucose metabolism disorders by regulating the PI3K/AKT/GSK3β signaling pathway.